Semi-Annual Statement Of Income And Retained Earnings

Mochida Pharmaceutical Co.,Ltd. - Filing #7555476

Concept 2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
6,411,000,000 JPY
8,507,000,000 JPY
14,392,000,000 JPY
11,367,000,000 JPY
Non-operating income
Non-operating income
2,606,000,000 JPY
665,000,000 JPY
455,000,000 JPY
2,218,000,000 JPY
Non-operating expenses
Non-operating expenses
47,000,000 JPY
87,000,000 JPY
48,000,000 JPY
45,000,000 JPY
Ordinary profit (loss)
8,971,000,000 JPY
9,085,000,000 JPY
14,799,000,000 JPY
13,539,000,000 JPY
Extraordinary income
Extraordinary income
6,000,000 JPY
13,000,000 JPY
564,000,000 JPY
526,000,000 JPY
Extraordinary losses
Extraordinary losses
47,000,000 JPY
54,000,000 JPY
771,000,000 JPY
638,000,000 JPY
Profit (loss) before income taxes
8,930,000,000 JPY
9,044,000,000 JPY
14,591,000,000 JPY
13,427,000,000 JPY
Income taxes - current
1,273,000,000 JPY
2,014,000,000 JPY
3,215,000,000 JPY
2,290,000,000 JPY
Income taxes - deferred
406,000,000 JPY
380,000,000 JPY
807,000,000 JPY
695,000,000 JPY
Profit (loss)
7,250,000,000 JPY
7,250,000,000 JPY
7,250,000,000 JPY
7,250,000,000 JPY
6,649,000,000 JPY
10,441,000,000 JPY
10,441,000,000 JPY
10,441,000,000 JPY
10,569,000,000 JPY
10,441,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.